| 000 | 01771 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513193953.0 | ||
| 264 | 0 | _c19991201 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a1080-7683 | ||
| 024 | 7 |
_a10.1089/jop.1999.15.425 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartidis, A | |
| 245 | 0 | 0 |
_aCorticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. _h[electronic resource] |
| 260 |
_bJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics _cOct 1999 |
||
| 300 |
_a425-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 |
_aEye Infections, Fungal _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFovea Centralis _xblood supply |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 |
_aHistoplasmosis _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriamcinolone _xadverse effects |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aMiller, D G | |
| 700 | 1 | _aCiulla, T A | |
| 700 | 1 | _aDanis, R P | |
| 700 | 1 | _aMoorthy, R S | |
| 773 | 0 |
_tJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics _gvol. 15 _gno. 5 _gp. 425-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/jop.1999.15.425 _zAvailable from publisher's website |
| 999 |
_c10487618 _d10487618 |
||